Studies
Every study below is enrolling volunteers now. Open one to see who can take part, then apply in a few minutes.
Recruiting
We're looking for adults aged 18 and older who have: A confirmed liver disease called non-alcoholic steatohepatitis (NASH) or metabolic-associated steatohepatitis (MASH) A body mass index (BMI) of 27 or more, or 25 or more if you're Asian. Unfortunately, if you have a history of other chronic liver diseases or high alcohol intake, you won't be able to participate.
Recruiting
Join us to explore a new treatment option for adults with Graves' disease who are experiencing hyperthyroidism.
Recruiting
Join us to explore a new treatment option for adults with IBS-D and IBS-M. This study has two parts.
Recruiting
Join our study if you're an adult aged 18 or older living with obesity and have: a confirmed liver disease called NASH (non-alcoholic steatohepatitis) or MASH (metabolic associated steatohepatitis) and moderate or advanced liver fibrosis. Unfortunately, if you have a history of other liver diseases or chronic alcohol use, you won't be able to participate. This study aims to see if a new medicine can help improve liver function for those with NASH/MASH and liver fibrosis.
Recruiting
Psoriatic arthritis (PsA) is a long-lasting condition that causes inflammation in the joints and skin. This study aims to learn more about the safety and effectiveness of a treatment called zasocitinib for adults with PsA over an extended period.
Recruiting
Join us in a study to explore a new treatment that may help improve liver health for those with MASH and specific fibrosis stages. We want to see how safe and effective this treatment is compared to a placebo.
Recruiting
Join us to explore the safety and comfort of a new treatment for people with known or suspected MASH and fibrosis stages F2 or F3.
Recruiting
This study aims to see how well adding a new treatment can help people with moderate-to-severe plaque psoriasis and obesity or overweight who also have at least one weight-related health issue. The study will last up to 12 months.
Recruiting
Join us in a study to see how well a new treatment can help prevent C. difficile infections from coming back in adults aged 18 and older.
Recruiting
Psoriatic arthritis (PsA) is a long-lasting condition that causes inflammation in the joints and skin for those with psoriasis (PsO). This study aims to see how well a new treatment works for people with active PsA who haven't used certain other medications before.
Recruiting
Join us in a study designed to learn more about a new treatment for rheumatoid arthritis (RA). This study has two parts: Part A includes 5 different treatment groups, and Part B focuses on one group. We want to understand how safe and effective this treatment is for adults with moderate to severe RA.
Recruiting
Join us in a study to see how well a new treatment works when combined with an existing medication for adults with moderately to severely active ulcerative colitis (UC). This study will last about 118 weeks, including 104 weeks of treatment and up to 21 visits.
Not sure which study fits?
Tell us about your health and we'll let you know which studies you may qualify for, now or in the future.